DIFFERENTIATING TROPONIN I AND CK-MB IN MYOCARDIAL INFARCTION DIAGNOSIS: A NOVEL APPROACH TO BIOMARKER COMPARISON
DOI:
https://doi.org/10.71000/safhjb49Keywords:
Myocardial infarction, Troponin I, Creatine Kinase-MB, Sensitivity, Specificity, Diagnostic Accuracy, , , ROC CurveAbstract
Background: Myocardial infarction (MI) is a life-threatening condition characterized by reduced blood supply to cardiac tissue, often leading to irreversible myocardial damage. Early and accurate diagnosis is essential to reduce complications and mortality. Biomarkers such as cardiac Troponin I (cTnI) and Creatine Kinase-MB (CK-MB) are central to MI detection. While cTnI is highly specific to cardiac tissue, CK-MB plays a supplementary role, especially in identifying reinfarction due to its shorter half-life and rapid kinetics.
Objective: To compare the diagnostic sensitivity and specificity of Troponin I and CK-MB in patients with acute myocardial infarction (AMI) and to determine the broader diagnostic window and reliability of Troponin I in both early and late phases of MI.
Methods: This cross-sectional, retrospective study included 65 MI patients (69.23% females, 30.77% males) with a mean age of 53 years, conducted over four months at two tertiary hospitals in Lahore. Blood samples were collected within six hours of symptom onset and analyzed using Beckman Coulter AU480 and Microlab 300 analyzers. Descriptive statistics, Pearson correlation, independent t-tests, and ROC curve analysis were used. Troponin I and CK-MB levels were compared for diagnostic accuracy, gender-based differences, and inter-marker correlation using SPSS version 25, with significance set at p < 0.05.
Results: Troponin I demonstrated a sensitivity of 95% and specificity of 97.4%, compared to CK-MB’s sensitivity of 96.4% and specificity of 85.8%. Mean Troponin I was 25.41 ng/mL (SD = 15.86) and CK-MB was 118.87 ng/mL (SD = 57.43). Pearson correlation showed a weak, non-significant relationship (r = 0.023, p = 0.859). ROC analysis revealed higher diagnostic accuracy for Troponin I (AUC = 0.92) versus CK-MB (AUC = 0.78). No significant gender-based differences were noted.
Conclusion: Troponin I outperforms CK-MB in terms of diagnostic accuracy, specificity, and clinical reliability for myocardial infarction. CK-MB may retain value in early detection, but Troponin I should remain the primary biomarker for precise diagnosis. Future research should focus on integrating additional biomarkers to further enhance diagnostic strategies.
References
Wang Y, Wei W, Han Z, Guan X, Yang Y, Li T, et al. Acoustic Streaming Tunnel Enables Particle Velocity Stretching in Multiplex Flow Cytometry. Anal Chem. 2024;96(41):16397-405.
Yang Y, Han J, Lilly RG, Yang Q, Guo Y. Bergapten mediated inflammatory and apoptosis through AMPK/eNOS/AKT signaling pathway of isoproterenol-induced myocardial infarction in Wistar rats. J Biochem Mol Toxicol. 2022;36(9):e23143.
Mele M, Mautone F, Ragnatela I, D'Alessandro D, Rossi LU, Granatiero M, et al. Biomarker profiles that differentiate type-1 and type 2 myocardial infarction. Heart Lung. 2025;70:230-5.
Li X, Xu C, Chen H, Yi F, Liao J, Han J, et al. A capillary-based microfluidic chip with the merits of low cost and easy fabrication for the rapid detection of acute myocardial infarction. Talanta. 2023;265:124924.
Guo LL, Chen HH, Qu FC, Lu QH. Clinical significance of miR-492 in peripheral blood of acute myocardial infarction. Eur Rev Med Pharmacol Sci. 2020;24(17):9041-5.
Sahin A, Avci A, Cinar H, Aksay E, Simsek Y, Tatar SD, et al. D-dimer/high-sensitivity troponin I ratio in the diagnosis of acute pulmonary embolism and/or non-ST-elevation myocardial infarction. Medicine (Baltimore). 2025;104(20):e41975.
Moon MG, Yoon CH, Lee K, Kang SH, Youn TJ, Chae IH. Evaluation of Heart-type Fatty Acid-binding Protein in Early Diagnosis of Acute Myocardial Infarction. J Korean Med Sci. 2021;36(8):e61.
Shibata M, Sugimoto M, Watanabe N, Namiki A. Exploring Novel Biomarkers for an Acute Coronary Syndrome Diagnosis Utilizing Plasma Metabolomics. Int J Mol Sci. 2024;25(12).
Zeng H, Hu F, Duan Y, Li H, Wang Y. Expression of lncRNA APF in Peripheral Blood of Patients with Acute Myocardial Infarction Caused by Coronary Heart Disease and its Clinical Significance. Int Heart J. 2022;63(4):742-8.
Song L, Wang Y, Guan C, Zou T, Sun Z, Xie L, et al. Impact of Periprocedural Myocardial Injury and Infarction Definitions on Long-Term Mortality After Chronic Total Occlusion Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2021;14(11):e010923.
Baroni S, Gabrielli M, Ferrigno F, Franceschi F, Urbani A. Lack of utility of CK-MB in combination with troponin I for the diagnosis of acute coronary syndrome. Intern Emerg Med. 2020;15(7):1345-6.
Lee H, Kang H, Chae H, Oh EJ. Limited Contribution of Creatine Kinase-Myocardial Band Alongside High-Sensitivity Cardiac Troponin in Diagnosing Acute Myocardial Infarction in an Emergency Department. Ann Lab Med. 2024;44(6):586-90.
Pan T, Jiang CY, Zhang H, Han XK, Zhang HT, Jiang XY, et al. The low-dose colchicine in patients after non-CABG cardiac surgery: a randomized controlled trial. Crit Care. 2023;27(1):49.
Macchiusi A, Marino G, Vitillo M, Colivicchi F. [Marked increase in high-sensitivity troponin I without evidence of acute coronary syndrome]. G Ital Cardiol (Rome). 2021;22(2):149-51.
Lee H, Kim W, Song MY, Kim DH, Jung HS, Kim W, et al. One-Stop Plasmonic Nanocube-Excited SERS Immunoassay Platform of Multiple Cardiac Biomarkers for Rapid Screening and Progressive Tracing of Acute Myocardial Infarction. Small. 2024;20(8):e2304999.
Yuan Y, Zhong Y, Yang Y, Li K. Rapid diagnosis of acute myocardial infarction through integrated microfluidic chips for detection of characteristic targets. Anal Biochem. 2024;689:115502.
Liu Y, Gao R, Zhuo Y, Wang Y, Jia H, Chen X, et al. Rapid simultaneous SERS detection of dual myocardial biomarkers on single-track finger-pump microfluidic chip. Anal Chim Acta. 2023;1239:340673.
You W, Wu XQ, Wu ZM, Wang YF, Shen TT, Tang B, et al. Safety and efficacy of low-temperature RA-flush solution in patients with moderate-to-severe calcified lesions (LOTA-II): a randomized, double-blind, multicenter study. Sci Rep. 2025;15(1):18280.
Park JR, Ahn JH, Jung MH, Kim JH, Kang MG, Kim KH, et al. Serum microRNA-185 Levels and Myocardial Injury in Patients with Acute ST-segment Elevation Myocardial Infarction. Intern Med. 2022;61(2):151-8.
Ma XY, Wang TQ, Tang KS, Yang YQ, Bai ZX, Zhang X, et al. Study on forensic diagnostic biomarker combination for acute ischemia heart disease based on postmortem biochemistry. J Forensic Leg Med. 2025;110:102825.
Hu W, Yang C, Guo X, Wu Y, Loh XJ, Li Z, Wu YL, Wu C. Research advances of injectable functional hydrogel materials in the treatment of myocardial infarction. Gels. 2022 Jul 6;8(7):423.
Katrukha IA, Katrukha AG. Myocardial Injury and the Release of Troponins I and T in the Blood of Patients. Clinical chemistry. 2021 Jan;67(1):124-30.
Hwang SY, Kim SH, Uhm IA, Shin JH, Lim YH. Prognostic implications for patients after myocardial infarction: an integrative literature review and in-depth interviews with patients and experts. BMC Cardiovascular Disorders. 2022 Aug 2;22(1).
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Sheraz Ali, Usama Abid, Tasra Bibi, M. Saim Qasim, Shahid Sultan, Hafiz Ayaz Ahmad, Sidra Iqbal (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
